Bristol-Myers Squibb Company
Nucleic acids encoding an anti-CD40 antibody
Last updated:
Abstract:
Provided herein are agonistic antibodies, or antigen binding portions thereof, that bind to human CD40. Such antibodies optionally comprise Fc regions with enhanced specificity for Fc.gamma.RIIb. The invention also provides methods of treatment of cancer or chronic infection by administering the antibodies of the invention to a subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
30 Apr 2019
Issue date:
24 Nov 2020